FDA spells out the rules and re­stric­tions for states seek­ing to im­port drugs from Cana­da

The FDA is of­fer­ing more of an ex­pla­na­tion of the guardrails around its pro­gram that may soon al­low states to im­port pre­scrip­tion drugs in some se­lect cir­cum­stances from Cana­da, but on­ly if such im­ports will re­sult in sig­nif­i­cant cost re­duc­tions for con­sumers.

While the agency has yet to sign off on any of the 5 state plans in the works so far, and PhRMA’s suit to block the Trump-era rule al­low­ing such im­ports is stalled, the new Q&A guid­ance spells out the var­i­ous re­stric­tions that states will have to abide by, po­ten­tial­ly sig­nal­ing that a state ap­proval is com­ing.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.